HON vs PPCB · P/E 36, rev $9.72B vs P/E 0.0, $3.9M cap
Honeywell International Inc (HON) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Honeywell International Inc (HON) is a conglomerates company listed on NASDAQ. It is led by Vimal Kapur.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported HON revenue for 2026-06-30 was $9.72B. Net income was $5.68B. Revenue was up 6.3% from 2026-03-31 to 2026-06-30. HON currently screens at market cap $144.86B and trailing P/E 36.5.
PPCB does not have a complete income-statement cache yet.
HON currently screens at market cap $144.86B and trailing P/E 36.5. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the HON and PPCB stock pages for the full models.
Not investment advice.